Hungarian competition authorities have reportedly raided the local offices of French pharmaceutical conglomerate Sanofi in part of an investigation into suspicions that the company abused its market dominance.
Reports say the competition regulator GVH searched the offices on July 22; Sanofi confirmed the searches and said the company is fully cooperating with the investigation.
The GVH’s raids mark the launch of an investigation into concerns that the company abused its market power in regards to its wholesale trade contracts. Authorities said Sanofi refused to sign a contract with a Hungarian wholesale drug company. In a statement, GVH said that Sanofi’s practices to choose wholesale partners “is not based on the expected real economic efficiency of the link, while putting certain groups of market players into unjustified disadvantageous position relative to incumbent market players.”
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Competition Commission of India to Probe AI Landscape for Competition
Apr 23, 2024 by
CPI
Canada’s Agricultural Giants in Antitrust Spotlight
Apr 23, 2024 by
CPI
US House Passes Bill That Could Lead to TikTok Ban
Apr 23, 2024 by
CPI
ADM CFO Resigns Amidst DOJ Investigation Into Accounting Issues
Apr 23, 2024 by
CPI
FTC Throws the Bag: Tapestry’s Capri Deal Blocked Over Market Monopoly Concerns
Apr 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI